Radium-223 ( Alpharadin): A novel Radiopharmaceutical that Prolongs Survival in Bone Metastatic Disease

 

The following question is for the Ask Dr Barken

Call In Show on Tuesday, March 13th at 6pm Pacific

Time.  Dial 1-877-727-3301 to hear the program.

Where can I get Alpharadin? What criteria will I need to meet to get this treatment?


 

The related article of the week:

Radium-223: A novel radio-pharmaceutical that prolongs

survival in advanced prostate cancer.   Oliver Sartor M.D.

Prostate Cancer Communication Volume 28, No 1, pp 9, March 2012 ( PAACT Newsletter – Richard Profit, Editor and President)

Video Blog Presentation:
Dr. Barken answers the questions and presents a video
commentary about the expanded access to the following
study:  Radium-223 Chloride (Alpharadin) in Castration-
Resistant Prostate Cancer Patients.
This entry was posted in Ask Dr. Barken, Bone Metastases, Castration Resistant Prostate Cancer, Metastatic Disease, Metastatic Prostate Cancer Disease, Prostate Cancer, Radiation treatment, Survival prostate cancer, Treatments for Prostate Cancer and tagged , . Bookmark the permalink.